Annex Advisory Services LLC bought a new stake in HealthStream, Inc. (NASDAQ:HSTM – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 36,140 shares of the technology company’s stock, valued at approximately $1,149,000.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Quarry LP acquired a new position in shares of HealthStream in the 3rd quarter valued at approximately $27,000. GAMMA Investing LLC increased its position in HealthStream by 36.0% during the 3rd quarter. GAMMA Investing LLC now owns 1,355 shares of the technology company’s stock worth $39,000 after purchasing an additional 359 shares in the last quarter. Point72 DIFC Ltd acquired a new position in HealthStream during the 2nd quarter worth approximately $38,000. Copeland Capital Management LLC acquired a new position in HealthStream during the 3rd quarter worth approximately $63,000. Finally, CWM LLC increased its position in HealthStream by 64.2% during the 3rd quarter. CWM LLC now owns 4,448 shares of the technology company’s stock worth $128,000 after purchasing an additional 1,739 shares in the last quarter. 69.58% of the stock is currently owned by institutional investors and hedge funds.
HealthStream Price Performance
HSTM opened at $31.88 on Tuesday. HealthStream, Inc. has a fifty-two week low of $23.92 and a fifty-two week high of $33.52. The firm has a market capitalization of $969.79 million, a price-to-earnings ratio of 49.05, a PEG ratio of 4.09 and a beta of 0.40. The company’s 50 day moving average price is $32.09 and its two-hundred day moving average price is $30.03.
Analysts Set New Price Targets
HSTM has been the subject of a number of research analyst reports. Craig Hallum upgraded shares of HealthStream to a “strong-buy” rating in a research report on Thursday, October 17th. Canaccord Genuity Group upped their price objective on shares of HealthStream from $28.00 to $29.00 and gave the stock a “hold” rating in a research report on Wednesday, October 23rd. Finally, Barclays upped their price objective on shares of HealthStream from $32.00 to $34.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 23rd. One analyst has rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Buy” and an average target price of $31.50.
View Our Latest Stock Report on HealthStream
HealthStream Profile
HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company’s solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.
Further Reading
- Five stocks we like better than HealthStream
- What is Forex and How Does it Work?
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
- What is a buyback in stocks? A comprehensive guide for investors
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
Want to see what other hedge funds are holding HSTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthStream, Inc. (NASDAQ:HSTM – Free Report).
Receive News & Ratings for HealthStream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream and related companies with MarketBeat.com's FREE daily email newsletter.